Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: National data from Japan
Open accessAbstract
Primary biliary cirrhosis (PBC) primarily affects females and is rarely complicated by hepatocellular carcinoma (HCC). Although the HCC incidence in PBC patients is low, several characteristics and risk factors associated with its development have been reported. In this study, national data concerning the current status of carcinogenesis in PBC patients in Japan are reviewed. Using data from two national questionnaire surveys, we investigated the clinicopathological findings associated with HCC in PBC patients. According to the data of all reviewed PBC patients, the HCC incidence was 2.4% (71/2946). The HCC incidence by gender was 5.1% (19/370) in males and 2.0% (52/2576) in females, and the proportion of males was 26.7%. Prognosis was significantly poorer in the PBC patients with HCC than in those without. Multivariate analysis of risk factors associated with HCC by gender revealed histological stage at the time of PBC diagnosis as an independent risk factor associated with the development of HCC in females, but not in males. Furthermore, data from another national survey of 178 PBC patients with HCC (male/female = 49/129; proportion of males 27.5%) revealed that the duration between the diagnosis of PBC and that of HCC was significantly shorter in males than in females. In addition, histological stage at the time of HCC diagnosis was an independent risk factor for HCC in females, whereas no risk factors were identified in males. Conclusion: these data indicate that males are at risk of developing HCC at any histological stage of PBC. Therefore, male PBC patients in particular should be carefully screened for HCC from the early stages of PBC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The impact of ethnicity on presentation is not well described, but there are reports internationally of how ethnicity affects the presentation of autoimmune liver disease.
“The impact of ethnicity on presentation is not well described, but there are reports internationally of how ethnicity affects the presentation of autoimmune liver disease, and clinicians should be aware that classical descriptions of disease are frequently derived from Caucasian-only populations.32–36”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [34]
The incidence rates of hepatocellular carcinoma in all patients with primary biliary cholangitis are similar across different regions, at 3.4-3.6 cases per 1000 patient-years.
“The incidence rates of hepatocellular carcinoma in all patients with primary biliary cholangitis are similar across different regions: 3•4-3•6 cases per 1000 patient-years.[77][78][79]”
From Primary biliary cholangitis. (2024) · cites this paper as [78]
Risk factors for developing hepatocellular carcinoma in patients with primary biliary cholangitis include male sex, advanced histological stage, cirrhosis, high alcohol intake, metabolic-associated factors such as overweight or diabetes, and treatment response to ursodeoxycholic acid.
“Risk factors for developing hepatocellular carcinoma include male sex, advanced histological stage, cirrhosis, high alcohol intake, and metabolic-associated factors, such as overweight or presence of diabetes, and treatment response to ursodeoxycholic acid.[77][78][79][80]”
From Primary biliary cholangitis. (2024) · cites this paper as [78]
The citation lists haven’t been fetched yet
References 26 · Cited by 87
- Authors
- Harada, K., Hirohara, J., Ueno, Y., Nakano, T., Kakuda, Y., Tsubouchi, H., Ichida, T., & Nakanuma, Y.
- Affiliations
- Kanazawa University (JP)
- Kansai Medical University (JP)
- Yamagata University (JP)
- Kagoshima University (JP)
- Juntendo University (JP)
- Corresponding author
- Harada, Kenichi
- Venue
- Hepatology
- Published
- 2013-05
- Volume
- 57
- Issue
- 5
- Pages
- 1942-1949
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2049032735
- Cited by
- 87
- References
- 26
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 17 · 2013: 7
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Hepatology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Society for the Promotion of Science (23590393)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- hepatocellular carcinoma, primary biliary cirrhosis, HCC incidence, risk factors, sex differences, histological stage, prognosis, HCC screening
- MeSH terms
- Aged, Female, Health Surveys, Carcinoma, Hepatocellular, Humans, Japan, Liver Cirrhosis, Biliary, Liver Neoplasms, Male, Middle Aged, Prognosis, Surveys and Questionnaires, Risk Factors, Incidence, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review